HDAC9 and cancer: After these initial experiments, which showed that analog APCS-540 possessed the highest anti-tumor activity, we investigated its effect on cancer cell survival in comparison to Tideglusib (GSK3Β inhibitor) and SAHA (HDAC inhibitor) alone and in combination.